Cargando…
Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent
(166)Holmium-1,2-propylene di-amino tetra (methy1enephosphonicacid) ((166) Ho-PDTMP) complex was prepared successfully using an in-house synthesized PDTMP ligand and (166) HoCl (3) . Ho-166 chloride was obtained by thermal neutron irradiation (1 × 10 (13) n/cm (2) /s) of natural Ho (NO (3) ) (3) sam...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149765/ https://www.ncbi.nlm.nih.gov/pubmed/25191109 http://dx.doi.org/10.4103/1450-1147.138571 |
_version_ | 1782332812235374592 |
---|---|
author | Zolghadri, Samaneh Jalilian, Amir Reza Yousefnia, Hassan Bahrami-Samani, Ali Ghannadi-Maragheh, Mohammad |
author_facet | Zolghadri, Samaneh Jalilian, Amir Reza Yousefnia, Hassan Bahrami-Samani, Ali Ghannadi-Maragheh, Mohammad |
author_sort | Zolghadri, Samaneh |
collection | PubMed |
description | (166)Holmium-1,2-propylene di-amino tetra (methy1enephosphonicacid) ((166) Ho-PDTMP) complex was prepared successfully using an in-house synthesized PDTMP ligand and (166) HoCl (3) . Ho-166 chloride was obtained by thermal neutron irradiation (1 × 10 (13) n/cm (2) /s) of natural Ho (NO (3) ) (3) samples (specific activity = 3-5 GBq/mg), dissolved in acidic media. Radiochemical purity of (166) Ho-PDTMP was checked by instant thin layer chromatography (>99%). Stability studies of the complex in the final preparation and in the presence of human serum were performed up to 72 h. The biodistribution of (166) Ho-PDTMP and (166) HoCl (3) in wild-type rats was checked in animal tissues up to 48 h. The produced (166) Ho-PDTMP properties suggest a possible new bone palliative therapeutic to overcome the metastatic bone pains. |
format | Online Article Text |
id | pubmed-4149765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41497652014-09-04 Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent Zolghadri, Samaneh Jalilian, Amir Reza Yousefnia, Hassan Bahrami-Samani, Ali Ghannadi-Maragheh, Mohammad World J Nucl Med Original Article (166)Holmium-1,2-propylene di-amino tetra (methy1enephosphonicacid) ((166) Ho-PDTMP) complex was prepared successfully using an in-house synthesized PDTMP ligand and (166) HoCl (3) . Ho-166 chloride was obtained by thermal neutron irradiation (1 × 10 (13) n/cm (2) /s) of natural Ho (NO (3) ) (3) samples (specific activity = 3-5 GBq/mg), dissolved in acidic media. Radiochemical purity of (166) Ho-PDTMP was checked by instant thin layer chromatography (>99%). Stability studies of the complex in the final preparation and in the presence of human serum were performed up to 72 h. The biodistribution of (166) Ho-PDTMP and (166) HoCl (3) in wild-type rats was checked in animal tissues up to 48 h. The produced (166) Ho-PDTMP properties suggest a possible new bone palliative therapeutic to overcome the metastatic bone pains. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4149765/ /pubmed/25191109 http://dx.doi.org/10.4103/1450-1147.138571 Text en Copyright: © World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Zolghadri, Samaneh Jalilian, Amir Reza Yousefnia, Hassan Bahrami-Samani, Ali Ghannadi-Maragheh, Mohammad Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title | Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title_full | Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title_fullStr | Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title_full_unstemmed | Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title_short | Development of (166)Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent |
title_sort | development of (166)holmium-1,2 propylene di-amino tetra (methy1enephosphonicacid) as a possible bone palliation agent |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149765/ https://www.ncbi.nlm.nih.gov/pubmed/25191109 http://dx.doi.org/10.4103/1450-1147.138571 |
work_keys_str_mv | AT zolghadrisamaneh developmentof166holmium12propylenediaminotetramethy1enephosphonicacidasapossiblebonepalliationagent AT jalilianamirreza developmentof166holmium12propylenediaminotetramethy1enephosphonicacidasapossiblebonepalliationagent AT yousefniahassan developmentof166holmium12propylenediaminotetramethy1enephosphonicacidasapossiblebonepalliationagent AT bahramisamaniali developmentof166holmium12propylenediaminotetramethy1enephosphonicacidasapossiblebonepalliationagent AT ghannadimaraghehmohammad developmentof166holmium12propylenediaminotetramethy1enephosphonicacidasapossiblebonepalliationagent |